Haas SJ - Search Results

1

Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.

Krum H, Haas SJ, Eichhorn E, Ghali J, Gilbert E, Lechat P, Packer M, Roecker E, Verkenne P, Wedel H, Wikstrand J. Krum H, et al. Among authors: haas sj. Eur Heart J. 2005 Oct;26(20):2154-8. doi: 10.1093/eurheartj/ehi409. Epub 2005 Jul 13. Eur Heart J. 2005. PMID: 16014644 Review.

2

Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials.

Dulin BR, Haas SJ, Abraham WT, Krum H. Dulin BR, et al. Among authors: haas sj. Am J Cardiol. 2005 Apr 1;95(7):896-8. doi: 10.1016/j.amjcard.2004.11.052. Am J Cardiol. 2005. PMID: 15781028

3

Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.

Haas SJ, Vos T, Gilbert RE, Krum H. Haas SJ, et al. Am Heart J. 2003 Nov;146(5):848-53. doi: 10.1016/S0002-8703(03)00403-4. Am Heart J. 2003. PMID: 14597934 Review.

4

Blood pressure effects of COX-2 inhibitors.

Krum H, Aw TJ, Liew D, Haas S. Krum H, et al. J Cardiovasc Pharmacol. 2006;47 Suppl 1:S43-8. doi: 10.1097/00005344-200605001-00008. J Cardiovasc Pharmacol. 2006. PMID: 16785828 Review.

5

Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure.

Aw TJ, Haas SJ, Liew D, Krum H. Aw TJ, et al. Among authors: haas sj. Arch Intern Med. 2005 Mar 14;165(5):490-6. doi: 10.1001/archinte.165.5.IOI50013. Epub 2005 Feb 14. Arch Intern Med. 2005. PMID: 15710786

6

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.

Phrommintikul A, Haas SJ, Elsik M, Krum H. Phrommintikul A, et al. Among authors: haas sj. Lancet. 2007 Feb 3;369(9559):381-8. doi: 10.1016/S0140-6736(07)60194-9. Lancet. 2007. PMID: 17276778

7

Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials.

Zimmet H, Porapakkham P, Porapakkham P, Sata Y, Haas SJ, Itescu S, Forbes A, Krum H. Zimmet H, et al. Among authors: haas sj. Eur J Heart Fail. 2012 Jan;14(1):91-105. doi: 10.1093/eurjhf/hfr148. Epub 2011 Nov 6. Eur J Heart Fail. 2012. PMID: 22065869 Free article.

8

Cardiovascular effects of selective cyclooxygenase-2 inhibitors.

Krum H, Liew D, Aw J, Haas S. Krum H, et al. Expert Rev Cardiovasc Ther. 2004 Mar;2(2):265-70. doi: 10.1586/14779072.2.2.265. Expert Rev Cardiovasc Ther. 2004. PMID: 15151474 Review.

9

Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials.

Wein L, Wein S, Haas SJ, Shaw J, Krum H. Wein L, et al. Among authors: haas sj. Arch Intern Med. 2007 Jul 23;167(14):1476-86. doi: 10.1001/archinte.167.14.1476. Arch Intern Med. 2007. PMID: 17646601 Clinical Trial.

10

Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis.

Chan CC, Reid CM, Aw TJ, Liew D, Haas SJ, Krum H. Chan CC, et al. Among authors: haas sj. J Hypertens. 2009 Dec;27(12):2332-41. doi: 10.1097/HJH.0b013e3283310dc9. J Hypertens. 2009. PMID: 19887957

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters